An Overview of Biopharmaceutical Difficulties and Furosemide’s Bioavailability Improvement. International Journal of Pharmaceutical Drug Design, [S. l.], v. 3, n. 1, p. 139–143, 2026. DOI: 10.62896/ijpdd.3.1.19. Disponível em: https://ijpdd.org/index.php/files/article/view/369. Acesso em: 29 apr. 2026.